Brokerage notes released today pointed out several stocks that could deliver more than 15% potential upside from current levels. The key highlights are presented in the table below:
| Stock | Brokerage | Call | CMP (₹) | Target (₹) | Upside % | Key reason |
|---|---|---|---|---|---|---|
| ICICI Bank | Morgan Stanley | Overweight | 1,417.20 | 1,800 | 27.0% | Loan growth acceleration expected from rate cuts, easing regulations, fiscal incentives; asset quality improving in unsecured loans |
| PNB Housing | Morgan Stanley | Overweight | 840.35 | 1,100 | 30.9% | Management reiterated 18% retail loan growth for FY26, affordable housing driving expansion, NIM guided at 3.6–3.7% |
| Avenue Supermarts | UBS | Buy | 4,720.00 | 5,600 | 18.6% | Growth expected to accelerate, strengthening e-commerce play, large structural opportunity; multiples could expand if revenue growth sustains above 20% |
| Shriram Finance | Morgan Stanley | Overweight | 626.00 | 740 | 18.2% | FY26 loan growth guidance at 15%, credit cost steady, NIMs to improve in Q3FY26 as liquidity impact eases |
| Sun Pharma | Citi | Buy | 1,620.80 | 2,180 | 34.6% | Innovation revenues to rise to $3.2bn by FY30, driven by Leqselvi, Unloxcyt, Ilumya’s PsA approval, US Medicare expansion |
These brokerages highlighted opportunities across financials, retail, NBFCs, and pharmaceuticals, pointing to strong growth drivers and margin visibility as the basis for their optimism.
Disclaimer: The views and investment recommendations expressed are those of the respective brokerages. These do not represent the views of this publication and should not be considered as investment advice. Investors are advised to consult their financial advisors before making any investment decisions.
